Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation
University of California, San Francisco · with La Clínica de La Raza Inc., Lifelong Medical Care · NCT05887557
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 15+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 400
- US sites recruiting
- 5
- Study start
- May 16, 2024
- Record last updated
- February 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). The hybrid type 2 implementation-effectiveness study involves a set of implementation strategies to support implementation of the integrated drop-in/mobile HIV care approach (i.e. the evidence-informed clinical intervention) at four diverse sites in San Francisco and Alameda counties in California. Sites include an academic clinic located at a public hospital (Ward 86) and a needle exchange site (San Francisco AIDS Foundation Syringe Access Site) in San Francisco and two Federally Qualified Health Centers serving diverse patient populations in Alameda County (Trust and La Clínica). The evidence-informed clinical intervention consists of four key components: 1) active referral to care sites; 2) drop-in, multidisciplinary HIV primary care; 3) mobile HIV care; and 4) staged escalation/de-escalation of care level as needed. The study will use RE-AIM to guide evaluation, with coprimary outcomes of Reach and HIV viral suppression, and mixed methods to assess intervention Adoption, Implementation, and Maintenance. The study draws on the CFIR framework to assess site-specific implementation determinants before and after the study period. The study will undertake micro-costing using a uniform cost data collection protocol to quantify the resources needed to carry out intervention activities.
Being studied: Active Referral; Drop-In Multidisciplinary HIV Care; Mobile HIV Care; Staged Care; Identify and prepare champions at referral sites; Audit and feedback at referral sites; Build a coalition among referral and clinical sites; Assess for readiness and identify barriers; Promote adaptability; Develop a formal implementation blueprint; Develop educational materials; conduct ongoing training; Create a learning collaborative
Conditions: HIV
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults or adolescents (≥15 years) living with HIV
- Most recent HIV viral load >200 copies/mL or off ART by ≥1 month by self-report
- Sub-optimal care engagement by self-report or chart history (defined as no current HIV primary care provider, no HIV primary care visit in the past 6 months, or ≥1 missed HIV primary care visit in the past 6 months)
- ≥1 major barrier to care engagement by self report or chart history (homelessness/ unstable housing, any mental health diagnosis, any illicit substance use).
Exclusion Criteria
Inability to give informed consent due to cognitive impairment, psychosis, or intoxication.
Recruiting US locations
La Clinica de la Raza, Inc
Oakland, CA 94601
Site contact: Jennifer Huggans-Zapeta, NP · jhzapeta@laclinica.org
Lifelong Medical Care
Oakland, CA 94612
Site contact: Kevin Critchlow, MD · kcritchlow@lifelongmedical.org
San Francisco AIDS Foundation
San Francisco, CA 94103
Site contact: Jorge Roman, NP · jroman@sfaf.org
San Francisco Department of Public Health Maria X Martinez Clinic
San Francisco, CA 94105
Site contact: Stephen Matzat, MD · stephen.matzat@sfdph.org
Zuckerberg San Francisco General Hospital
San Francisco, CA 94110
Site contact: Katerina Christopoulos, MD, MPH · 415-476-4082 · Katerina.Christopoulos@ucsf.edu
Study contacts (from the official record)
- Katerina Christopoulos, MD, MPH · 415-476-4082 · Katerina.Christopoulos@ucsf.edu
- Jennifer Cohen, MPA · Jennifer.Cohen@ucsf.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55